Halozyme Therapeutics Inc (NASDAQ:HALO)

22.41
BATS BZX Real-Time Price
As of 1:27pm ET
 +1.17 / +5.51%
Today’s Change
7.51
Today|||52-Week Range
22.64
+132.23%
Year-to-Date

Today’s Trading

Previous close21.24
Today’s open21.51
Day’s range21.43 - 22.64
Volume1,053,734
Average volume (3 months)1,359,635
Market cap$2.7B
Dividend yield--
Data as of 1:14pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+12.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book64.57

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+2.35+3.99%
RDUSRadius Health Inc+6.29+10.19%
NVAXNovavax Inc+0.48+4.55%
AXONAxovant Sciences Ltd-0.12-0.60%
Data as of 1:29pm ET, 06/30/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers